OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020
October 13, 2020 12:51 ET
|
OPKO Health, Inc.
MIAMI, Oct. 13, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial...
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
September 15, 2020 07:00 ET
|
OPKO Health, Inc.
MIAMI, Sept. 15, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces the initiation of a Phase 2 trial with RAYALDEE® as a treatment for mild-to-moderate COVID-19. The trial, “A...
OPKO Health to Participate in Two September Investment Conferences
September 02, 2020 16:05 ET
|
OPKO Health, Inc.
MIAMI, Sept. 02, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences. 13th Annual...
OPKO Health to Participate in BTIG Virtual Biotechnology Conference
August 05, 2020 15:35 ET
|
OPKO Health, Inc.
MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday,...
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
July 30, 2020 16:05 ET
|
OPKO Health, Inc.
MIAMI , July 30, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2020. Second Quarter Business...
OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020
July 27, 2020 08:00 ET
|
OPKO Health, Inc.
MIAMI, July 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2020, as well as discuss financial...
OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency
June 09, 2020 08:00 ET
|
OPKO Health, Inc.
MIAMI, June 09, 2020 (GLOBE NEWSWIRE) -- Following last October’s announcement of successful results of the global Phase 3 study of once-weekly somatrogon, an investigational agent for the treatment...
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
June 01, 2020 08:00 ET
|
OPKO Health, Inc.
MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has authorized OPKO to undertake a Phase 2 trial with...
OPKO Health to Present at the Jefferies Virtual Healthcare Conference
May 27, 2020 08:00 ET
|
OPKO Health, Inc.
MIAMI, May 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 2-4,...
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
May 06, 2020 16:05 ET
|
OPKO Health, Inc.
MIAMI, May 06, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2020. Business Highlights ...